Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data

Abstract

Background Advances in SARS-CoV-2 sequencing have enabled identification of new variants, tracking of its evolution, and monitoring of its spread. We aimed to use whole genome sequencing to describe the molecular epidemiology of the SARS-CoV-2 outbreak and to inform the implementation of effective public health interventions for control in Zimbabwe. Methods We performed a retrospective study of nasopharyngeal samples collected from nine laboratories in Zimbabwe between March 20 and Oct 16, 2020. Samples were taken as a result of quarantine procedures for international arrivals or to test for infection in people who were symptomatic or close contacts of positive cases. Samples that had a cycle threshold of less than 30 in the diagnostic PCR test were processed for sequencing. We began our analysis in July, 2020 (120 days since the first case), with a follow-up in October, 2020 (at 210 days since the first case). The phylogenetic relationship of the genome sequences within Zimbabwe and global samples was established using maximum likelihood and Bayesian methods. Findings Of 92 299 nasopharyngeal samples collected during the study period, 8099 were PCR-positive and 328 were available for sequencing, with 156 passing sequence quality control. 83 (53%) of 156 were from female participants. At least 26 independent introductions of SARS-CoV-2 into Zimbabwe in the first 210 days were associated with 12 global lineages. 151 (97%) of 156 had the Asp614Gly mutation in the spike protein. Most cases, 93 (60%), were imported from outside Zimbabwe. Community transmission was reported 6 days after the onset of the outbreak. Interpretation Initial public health interventions delayed onset of SARS-CoV-2 community transmission after the introduction of the virus from international and regional migration in Zimbabwe. Global whole genome sequence data are essential to reveal major routes of spread and guide intervention strategies. Funding WHO, Africa CDC, Biotechnology and Biological Sciences Research Council, Medical Research Council, National Institute for Health Research, and Genome Research Limited.

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study

“…Our study contributes to improved understanding on SARS-CoV-2 introduction and transmission patterns in sub-Saharan Africa countries ( Bugembe et al, 2020 ; Butera et al, 2021 ; Githinji et al, 2021 ; Mashe et al, 2021 ; Wilkinson et al, 2021 ). This knowledge has potential to inform the application of future mitigation strategies especially in light of the growing evidence that SARS-CoV-2 will be endemic in human populations ( Planas et al, 2021 ).…”

Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic

“…A study from Zimbabwe of the genomic epidemiology of the SARS-CoV-2 variants found that 60% of cases were imported, indicating that human movement is a key factor in its transmission, further supporting the importance of quarantine and restriction of human movements. 2 Rational development of COVID-19 vaccines also relies on mass-spectrometry (MS)-based characterization of the spike (S) glycoprotein of the virus, whose conformational dynamics is key for vaccine design. The viral S protein interacts with ACE2 on host cells, and antibodies that interfere with this by targeting the S protein can potentially neutralize the virus.…”

Observed strong pervasive positive selection in the N-terminal domain, receptor-binding domain and furin-cleavage sites of SARS-CoV-2 Spike protein sampled from Zimbabwean COVID-19 patients

“…A study about COVID-19 and SARS-CoV-2 in Zimbabwean patients has been done by Mashe et al . 2021, however the study was more focussed on the epidemiology of COVID-19.…”